Core One Labs Inc
CNSX:COOL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Core One Labs Inc
Common Shares Outstanding
Core One Labs Inc
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Core One Labs Inc
CNSX:COOL
|
Common Shares Outstanding
CA$46.7m
|
CAGR 3-Years
58%
|
CAGR 5-Years
36%
|
CAGR 10-Years
57%
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Common Shares Outstanding
$370.5m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Common Shares Outstanding
CA$368.3m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
14%
|
|
|
Cronos Group Inc
TSX:CRON
|
Common Shares Outstanding
$381.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
25%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Common Shares Outstanding
$76.8m
|
CAGR 3-Years
27%
|
CAGR 5-Years
38%
|
CAGR 10-Years
23%
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Common Shares Outstanding
CA$99.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
Core One Labs Inc
Glance View
Core One Labs, Inc. is a biotechnology company, which engages in the manufacture of cannabis-infused strips. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2011-08-17. The firm is focused on advancing psychedelic medicines to market through delivery systems and psychedelic assisted psychotherapy and active pharmaceutical ingredients (API) grade psilocybin manufacturing. Core One has developed its technology, thin film oral strip, which dissolves instantly when placed in the mouth and delivers organic molecules in precise quantities to the bloodstream, maintaining bioavailability. The firm also intends to develop and apply the technology to psychedelic compounds, such as psilocybin. Core One produce current Good Manufacturing Practice (cGMP) API grade psilocybin for use by pharmaceutical companies, API manufacturers and organizations conducting clinical trials, providing access to organizations. Core One also holds an interest in medical clinics, which maintain a combined database of approximately 275,000 patients.
See Also
What is Core One Labs Inc's Common Shares Outstanding?
Common Shares Outstanding
46.7m
CAD
Based on the financial report for Dec 31, 2023, Core One Labs Inc's Common Shares Outstanding amounts to 46.7m CAD.
What is Core One Labs Inc's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
57%
Over the last year, the Common Shares Outstanding growth was 26%. The average annual Common Shares Outstanding growth rates for Core One Labs Inc have been 58% over the past three years , 36% over the past five years , and 57% over the past ten years .
